Russia’s Vector is Working on Intranasal COVID-19 Vaccine

Apr 8, 2021 | EARNINGS

MOSCOW (Sputnik) – The Russian State Research Center of Virology and Biotechnology Vector has started developing a new coronavirus vaccine in the form of nasal drops, which will help produce immunity right at the “entrance gate” of the infection, Vector General Director Rinat Maksyutov said in an interview with Sputnik.

Read More

Pin It on Pinterest